Validity and Reliability Study of the Turkish Version of the Breast Cancer Stigma Scale: A Methodological Study.

IF 2.3 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Breast Care Pub Date : 2026-01-29 DOI:10.1159/000550063

Nurten Şişman, Zeynep Erdogan

{"title":"Validity and Reliability Study of the Turkish Version of the Breast Cancer Stigma Scale: A Methodological Study.","authors":"Nurten Şişman, Zeynep Erdogan","doi":"10.1159/000550063","DOIUrl":null,"url":null,"abstract":"Introduction: The purpose of this methodological and descriptive study was to conduct the validity and reliability study of the Breast Cancer Stigma Scale (BCSS) for the Turkish population of breast cancer patients.Methods: The sample of the study consisted of 150 female patients who were diagnosed with breast cancer, met the inclusion criteria, and applied to the oncology clinics and outpatient units of a university hospital. Data were collected through face-to-face interviews using a 13-item personal information form investigating patients' sociodemographic and disease-related characteristics, the BCSS, and the Patient Health Questionnaire-9 (PHQ-9). Language and content validity, criterion validity, construct validity, and reliability analyses of the scale were conducted sequentially. Descriptive statistical methods (number, percentage, mean, standard deviation), correlation analysis, Kruskal-Wallis test, Mann-Whitney U test, t-test, Cronbach's alpha analysis, confirmatory factor analysis, and exploratory factor analysis were used for data analysis.Results: The content validity index (CVI) value was found to be 1.0. The factor loadings of the scale ranged between 0.663 and 0.892, and the total explained variance was 73.89%. The Turkish version of the BCSS demonstrated excellent internal consistency (Cronbach's α = 0.70-0.92) and good construct validity (CFA fit indices: CFI = 0.97, TLI = 0.96, RMSEA = 0.05, SRMR = 0.05). The Cronbach's alpha coefficients for the subscales of the BCSS were 0.92 for the Body-Image Impairment (BI) subscale, 0.70 for the Social Isolation (SI) subscale, 0.78 for the Discrimination (D) subscale, 0.89 for the Internalized Stigma (IS) subscale, and 0.90 for the total the BCSS score. The Turkish version of the scale showed a good fit with the original model, confirming its four-factor structure.Conclusion: The Turkish version of the BCSS was found to be valid and reliable.","PeriodicalId":9310,"journal":{"name":"Breast Care","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12978814/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000550063","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The purpose of this methodological and descriptive study was to conduct the validity and reliability study of the Breast Cancer Stigma Scale (BCSS) for the Turkish population of breast cancer patients.

Methods: The sample of the study consisted of 150 female patients who were diagnosed with breast cancer, met the inclusion criteria, and applied to the oncology clinics and outpatient units of a university hospital. Data were collected through face-to-face interviews using a 13-item personal information form investigating patients' sociodemographic and disease-related characteristics, the BCSS, and the Patient Health Questionnaire-9 (PHQ-9). Language and content validity, criterion validity, construct validity, and reliability analyses of the scale were conducted sequentially. Descriptive statistical methods (number, percentage, mean, standard deviation), correlation analysis, Kruskal-Wallis test, Mann-Whitney U test, t-test, Cronbach's alpha analysis, confirmatory factor analysis, and exploratory factor analysis were used for data analysis.

Results: The content validity index (CVI) value was found to be 1.0. The factor loadings of the scale ranged between 0.663 and 0.892, and the total explained variance was 73.89%. The Turkish version of the BCSS demonstrated excellent internal consistency (Cronbach's α = 0.70-0.92) and good construct validity (CFA fit indices: CFI = 0.97, TLI = 0.96, RMSEA = 0.05, SRMR = 0.05). The Cronbach's alpha coefficients for the subscales of the BCSS were 0.92 for the Body-Image Impairment (BI) subscale, 0.70 for the Social Isolation (SI) subscale, 0.78 for the Discrimination (D) subscale, 0.89 for the Internalized Stigma (IS) subscale, and 0.90 for the total the BCSS score. The Turkish version of the scale showed a good fit with the original model, confirming its four-factor structure.

Conclusion: The Turkish version of the BCSS was found to be valid and reliable.

查看原文本刊更多论文

土耳其版乳腺癌耻感量表的效度和信度研究：一项方法学研究。

前言：本方法学和描述性研究的目的是对乳腺癌耻感量表（BCSS）在土耳其乳腺癌患者群体中的效度和信度进行研究。方法：选取符合入选标准的150例乳腺癌女性患者，应用于某大学附属医院肿瘤科门诊。通过面对面访谈收集数据，采用13项个人信息表调查患者的社会人口学和疾病相关特征，BCSS和患者健康问卷-9 （PHQ-9）。量表的语言和内容效度、标准效度、构念效度和信度依次进行分析。采用描述性统计方法（数量、百分比、平均值、标准差）、相关分析、Kruskal-Wallis检验、Mann-Whitney U检验、t检验、Cronbach's α分析、验证性因子分析、探索性因子分析进行数据分析。结果：内容效度指数（CVI）值为1.0。量表的因子负荷在0.663 ~ 0.892之间，总解释方差为73.89%。土耳其版本的BCSS具有良好的内部一致性（Cronbach’s α = 0.70-0.92）和良好的结构效度（CFA拟合指数：CFI = 0.97, TLI = 0.96, RMSEA = 0.05, SRMR = 0.05）。身体形象障碍（BI）子量表的Cronbach’s alpha系数为0.92，社会孤立（SI）子量表的Cronbach’s alpha系数为0.70，歧视(D)子量表的Cronbach’s alpha系数为0.78，内化污名（IS）子量表的Cronbach’s alpha系数为0.90。土耳其版本的量表显示出与原始模型的良好契合，证实了其四因素结构。结论：土耳其语版BCSS是有效可靠的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Care 医学-妇产科学

CiteScore

4.40

自引率

4.80%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Breast Care'' is a peer-reviewed scientific journal that covers all aspects of breast biology. Due to its interdisciplinary perspective, it encompasses articles on basic research, prevention, diagnosis, and treatment of malignant diseases of the breast. In addition to presenting current developments in clinical research, the scope of clinical practice is broadened by including articles on relevant legal, financial and economic issues.